limonin has been researched along with glycyrrhizic acid in 1 studies
| Studies (limonin) | Trials (limonin) | Recent Studies (post-2010) (limonin) | Studies (glycyrrhizic acid) | Trials (glycyrrhizic acid) | Recent Studies (post-2010) (glycyrrhizic acid) |
|---|---|---|---|---|---|
| 159 | 0 | 106 | 2,079 | 70 | 1,068 |
| Protein | Taxonomy | limonin (IC50) | glycyrrhizic acid (IC50) |
|---|---|---|---|
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | Homo sapiens (human) | 0.0115 | |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | Mus musculus (house mouse) | 0.0135 | |
| Corticosteroid 11-beta-dehydrogenase isozyme 2 | Homo sapiens (human) | 0.0007 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sahoo, SK; Vardhan, S | 1 |
1 other study(ies) available for limonin and glycyrrhizic acid
| Article | Year |
|---|---|
Computational studies on the interaction of SARS-CoV-2 Omicron SGp RBD with human receptor ACE2, limonin and glycyrrhizic acid.
Topics: Angiotensin-Converting Enzyme 2; COVID-19 Drug Treatment; Glycyrrhizic Acid; Humans; Limonins; Mutation; SARS-CoV-2 | 2022 |